retatrutide legal status Promises Big Weight Loss, but Safety Remains a Question Retatrutide is a new GLP-1

Several other indications are under study, including obstructive sleep apnea, MASLD, knee osteoarthritis, chronic kidney disease, and cardiovascular outcomes

GLP-1 receptor agonists are generally well-tolerated, but clinicians and patients must understand their adverse effect profile, particularly when considering use in individuals with eating disorders who may have unique vulnerabilities

What makes it work: The thigh is easy to access whether youre sitting or standing, and alternating between left and right legs gives each side a full two weeks to recover between injections

Any compounding pharmacy offering retatrutide is operating in a legally questionable space

You need both measurements to know what's happening

A: Slower gastric emptying and reduced thirst cues can lead to low hydration, even if youre drinking water